An analysis of HCPC fitness to practise hearings: Fit to Practise or Fit for Purpose? (vol 11, pg 382, 2017)

被引：0
|
作者：
Leigh, J.
Worsley, A.
McLaughlin, K.
机构：
来源：
ETHICS & SOCIAL WELFARE | 2018年 / 12卷 / 03期
关键词：
D O I：
10.1080/17496535.2017.1364490
中图分类号：
C916 [社会工作、社会管理、社会规划];
学科分类号：
1204 ;
摘要：
引用
收藏
页码：292 / 292
页数：1
相关论文
共 36 条
  • [31] Does money talk? A framing analysis of the Chinese Government's strategic communications in the establishment of the Asian Infrastructure Investment Bank (vol 11, pg 169, 2017)
    Lan, Xiaomeng
    CHINESE JOURNAL OF COMMUNICATION, 2019, 12 (03) : I - I
  • [32] P622 Efficacy of probiotics in inflammatory bowel disease: systematic review and meta-analysis (vol 11, pg S398, 2017)
    不详
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (01): : 149 - 149
  • [33] Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis (vol 19, pg 716, 2017)
    Tati, Swetha
    Fisk, John C.
    Abdullah, Julia
    Karacosta, Loukia
    Chrisikos, Taylor
    Philbin, Padraic
    Morey, Susan
    Ghazal, Diala
    Zalzala, Fatma
    Jessee, Joseph
    Quataert, Sally
    Koury, Stephen
    Moreno, David
    Eng, Jing Ying
    Glinsky, Vladislav V.
    Glinskii, Olga V.
    Sesay, Muctarr
    Gebhard, Anthony W.
    Birthare, Karamverr
    Olson, James R.
    Rittenhouse-Olson, Kate
    NEOPLASIA, 2018, 20 (01): : 118 - 118
  • [34] Margaret Atwood's Reception in Canada and the United States: A Comparative Analysis of North American Reviews of Her Novel The Blind Assassin (vol 11, pg 354, 2017)
    Nischik, Reingard M.
    CONTEMPORARY WOMENS WRITING, 2018, 12 (01) : 132 - 133
  • [35] The role of maintenance therapy in the treatment of elderly non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials (vol 11, pg 3435, 2017)
    Zhang, Liangze
    Gao, S.
    He, J.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 391 - 391
  • [36] 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial (vol 389, pg 1195, 2017)
    Cameron, D.
    Piccart-Gebhart, M. J.
    Gelber, R. D.
    LANCET, 2019, 393 (10176): : 1100 - 1100
1234